Major Update 2: Remdesivir for Adults With COVID-19: A Living Systematic Review and Meta-analysis for the American College of Physicians Practice Points-Reference-Cited by-同舟云学术

Major Update 2: Remdesivir for Adults With COVID-19: A Living Systematic Review and Meta-analysis for the American College of Physicians Practice Points

Published:2022-05 Issue:5 Volume:175 Page:701-709
ISSN:0003-4819
Container-title:Annals of Internal Medicine
language:en
Short-container-title:Ann Intern Med

Author:

Kaka Anjum S.¹^ORCID,MacDonald Roderick²,Linskens Eric J.²,Langsetmo Lisa²^ORCID,Vela Kathryn³^ORCID,Duan-Porter Wei⁴,Wilt Timothy J.⁴

Affiliation:

1. Minneapolis VA Section of Infectious Diseases and University of Minnesota School of Medicine, Minneapolis, Minnesota (A.S.K.)

2. Minneapolis VA Evidence Synthesis Program, Center for Care Delivery and Outcomes Research, Minneapolis, Minnesota (R.M., E.J.L., L.L.)

3. Portland VA Health Care System, Portland, Oregon (K.V.)

4. Minneapolis VA Evidence Synthesis Program, Center for Care Delivery and Outcomes Research, and University of Minnesota School of Medicine, Minneapolis, Minnesota (W.D., T.J.W.)

Publisher

American College of Physicians

Subject

General Medicine,Internal Medicine

Reference20 articles.

1. Remdesivir for Adults With COVID-19

2. Comparative therapeutic efficacy of remdesivir and combination lopinavir, ritonavir, and interferon beta against MERS-CoV

3. Remdesivir for the Treatment of Covid-19 — Final Report

4. Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial

5. Remdesivir for 5 or 10 Days in Patients with Severe Covid-19

Cited by 33 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Wave-Based Outcomes Comparison of Hospitalized COVID-19 Patients: A Retrospective Multicenter Cohort Study From Rural Appalachia;Cureus;2024-01-08

2. Remdesivir may hinder the function of Recombination Activating Gene-1 (RAG1);Medical Hypotheses;2024-01

3. Remdesivir for the Treatment of COVID-19: A Narrative Review;Infectious Diseases and Therapy;2024-01

4. Dauricine interferes with SARS-CoV-2 variants infection by blocking the interface between RBD and ACE2;International Journal of Biological Macromolecules;2023-12

5. Effectiveness and Safety of Remdesivir in Treating Hospitalised Patients with COVID-19: A Propensity Score Analysis of Real-Life Data from a Monocentric Observational Study in Times of Health Emergency;Clinical Drug Investigation;2023-09-22